首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process
【24h】

Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process

机译:开展以患者为中心的利益风险调查:社区参与的过程

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives: To provide a community-engaged process to inform the design of a stated-preferences experiment. The process involved integrating patients and caregivers of people with Duchenne/Becker muscular dystrophy, advocates, clinicians, and the sponsor in conceptualizing and developing a benefit-risk survey on the basis of phase III trial results. Methods: Our community-engagement process for the development of a stated-preference survey included a set of five guiding principles with a foundation in the principles of community-engaged research. Engagement efforts were carried out through an informal network of three committees. Members of the leadership, stakeholder, and review committees comprised patients, caregivers, clinicians, advocacy leadership, and industry representatives. Results: Committee members participated in 15 hours of formal engagement including interviews and conference calls that ranged from 45 to 90 minutes, plus additional less-formal ad hoc communication. Committees comprised 20 individuals across three committees including adults with DMD (n = 6), parents of children with DMD (n = 6), clinicians (n = 3), members of research and advocacy organizations (n = 4), and an industry representative (n = 1). Community engagement informed attribute selection, survey length, word choice, and eligibility criteria. Challenges in the process included managing diverse stakeholder perspectives, time requirements, and the inherent tension between outcomes used in clinical trials versus attributes that correspond to patient- and family-relevant outcomes. Conclusions: We demonstrated how community engagement can successfully influence study design to support the design of a relevant survey instrument that is ethical, acceptable, meaningful to the community, and enhances patient-centered benefit-risk assessment for regulatory decision making.
机译:目标:提供一个社区参与的过程,以告知设计特定偏好的实验。该过程涉及将患有Duchenne / Becker型肌营养不良症的患者和监护人,拥护者,临床医生和申办者整合在一起,以基于III期试验结果来概念化和开发一项受益风险调查。方法:我们制定陈述偏好调查的社区参与过程包括一套五项指导原则,并以社区参与研究的原则为基础。通过三个委员会的非正式网络开展了参与工作。领导,利益相关者和审查委员会的成员包括患者,护理人员,临床医生,倡导领导和行业代表。结果:委员会成员参加了15个小时的正式活动,包括从45分钟到90分钟的采访和电话会议,以及其他非正式的临时交流。委员会由三个委员会的20个人组成,其中包括DMD成人(n = 6),DMD儿童的父母(n = 6),临床医生(n = 3),研究和倡导组织的成员(n = 4)和一个行业代表(n = 1)。社区参与告知属性选择,调查时间,单词选择和资格标准。该过程中的挑战包括如何管理利益相关者的不同观点,时间要求以及临床试验结果与对应于患者和家庭相关结果的属性之间的内在矛盾。结论:我们证明了社区参与如何能够成功地影响研究设计,以支持对社区而言是合乎道德,可接受,有意义的相关调查工具的设计,并增强以患者为中心的利益风险评估,以进行监管决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号